Related Experiment Videos
[Study on dopamine D2 binding capacity in vascular parkinsonism]
H Terashi1, K Nagata, Y Hirata
1Department of Neurology, Research Institute for Brain and Blood Vessels, Third Department of Internal Medicine, Tokyo Medical University.
Rinsho Shinkeigaku = Clinical Neurology
|May 8, 2002
Summary
This study found that striatal dopamine D2 receptor binding is not severely impaired in vascular parkinsonism (VP). These findings suggest dopamine D2 receptor function may not be the primary cause of parkinsonism in VP patients.
Area of Science:
- Neuroscience
- Radiology
- Neurology
Background:
- Vascular parkinsonism (VP) is a condition characterized by parkinsonian symptoms resulting from cerebrovascular disease.
- The role of striatal dopamine D2 receptor function in the pathophysiology of VP remains unclear.
Purpose of the Study:
- To investigate the involvement of striatal dopamine D2 receptor function in the development of vascular parkinsonism.
- To assess dopamine D2 receptor binding availability in patients with VP using positron emission tomography (PET).
Main Methods:
- A PET study was conducted on 9 patients with VP using [11C] N-methylspiperone as a tracer.
- Striatal dopamine D2 receptor binding availability (k3) was semiquantitatively determined.
- Values were compared to normal volunteers and correlated with clinical severity (Hoehn and Yahr stage).
Main Results:
- Striatal dopamine D2 receptor binding was not severely impaired in most VP patients.
- No evident correlation was found between D2 receptor binding and the Hoehn and Yahr stage.
- Laterality of receptor binding did not consistently match the laterality of parkinsonian symptoms.
Conclusions:
- Striatal dopamine D2 receptor binding is not significantly impaired in vascular parkinsonism.
- Dopamine D2 receptor function does not appear to be primarily associated with the development of parkinsonism in VP.
- Further research is needed to elucidate the underlying mechanisms of VP.